Evidence map›Paper›PMID 41281587›Full record

ArticleNumerical algebra, control and optimization2025

A novel machine-learning based optimization: identifying new treatment regimens for tuberculosis.

Maral Budak, Pariksheet Nanda, Denise Kirschner

Abstract read
In one paragraph

Article in Numerical algebra, control and optimization, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maral BudakDept. of Microbiology and Immunology, University of Michigan Medical School 48109-5620, Ann Arbor, MI, United States.
Pariksheet NandaDept. of Microbiology and Immunology, University of Michigan Medical School 48109-5620, Ann Arbor, MI, United States.
Denise KirschnerDept. of Microbiology and Immunology, University of Michigan Medical School 48109-5620, Ann Arbor, MI, United States.

Funding

Lesion-centric optimization of multidrug therapies for tuberculosisR01AI150684 · NIAID · TUFTS UNIVERSITY BOSTON · PI ALDRIDGE, BREE BEARDSLEY, KIRSCHNER, DENISE E · 2020 to 2024
$4.2M
High-Performance Computing Cluster for Biomedical ResearchS10OD026825 · OD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ATHEY, BRIAN DAVID · 2020 to 2020
$600k
NIAID NIH HHS R01 AI150684NIH HHS S10 OD026825
6 · The paper itself

Abstract

Identifying optimization in a system from any discipline requires identifying ways to either maximize or minimize objectives of interest-or even trade-offs between these choices where goals must be balanced. Traditionally, optimal control theory has been used specifically for applications that are represented by ordinary differential equations. Here, we introduce a new approach to optimization that can be applied not only to ordinary differential-equation based systems, but importantly to other more complex models, such as agent-based model systems. To this end, we create a novel machine learning optimization pipeline that uses a Kriging-based surrogate model to predict objective functions. We use a Pareto optimization algorithm to identify regimens that maximize improvement to the predicted optimal set and then rank these findings. As an example, we apply this to a model system that captures drug treatment of hosts during infection with

Indexed as

Agent-based modelDrug treatmentMachine learningMathematical biologyOptimizationRankingTuberculosis

Identifiers

PMID41281587
PMCPMC12637175

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.